glp 1 serotonin signaling to regulate energy metabolism: a gut microbiota perspective A Comprehensive Review of the

Two additional Phase 3 oral assets are particularly useful to watch because they represent next entrants rather than franchise conversions: HDM1002 (conveglipron) HDM1002 is being positioned publicly as a selective oral small-molecule GLP-1R agonist for type 2 diabetes and obesity

It helps the body burn calories even at rest

The provider asks follow-up questions, you respond, and the conversation continues until the provider has enough information to make a clinical decision

Nutrient-dense foods: Eating a well-balanced, nutrient-dense diet with plenty of fruits, vegetables, whole grains, and healthy fats supports overall health and helps prevent vitamin and mineral deficiencies

GLP-1 drugs are FDA-approved for patients with obesity, those who are overweight with related health conditions and those with specific health issues

Your PlexusDx provider can discuss both options and help you decide based on your symptom timeline and goals